| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2578852 | Thérapie | 2014 | 7 Pages |
Abstract
Our results show the improvement of ARV-induced ADRs reporting by Nadis® which could be used to reduce the rate of under-reporting in patients exposed to these drugs.
Keywords
CDCBNPVINSTIVirus de l’hépatite BVHBIPBVIHAMMRCPARVATCvHCPharmacovigilancedFGEffet indésirablenotification spontanéerésumé des caractéristiques du produitAntirétrovirauxMedical Dictionary for Regulatory ActivitiesAdverse drug reactionEffets indésirablesautorisation de mise sur le marchéCenters for Disease Control and PreventionCentre hospitalier universitaireInsuffisance rénaleDébit de filtration glomérulaireVirus de l’hépatite CChuSpontaneous reporting
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Liselotte Pochard, Laurent Hauviller, Lise Cuzin, Fréderic Eyvrard, Agnès Sommet, Jean-Louis Montastruc, Haleh Bagheri,